Premium
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin‐American cohort of 212 patients
Author(s) -
Lazzarino Carolina,
Arbelbide Jorge,
Schuster Sergio,
Crisp Renée,
González Jacqueline,
Tavares Renato,
Perusini Maria Agustina,
Di Stefano Marco,
Pintos Noemí,
Espinosa Daniel,
Pimentel Mayra,
Rosenhain Mariana,
Serrano Juan Carlos,
Enrico Alicia,
Iastrebner Marcelo,
Belli Carolina B.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25987
Subject(s) - medicine , international prognostic scoring system , myelodysplastic syndromes , hypomethylating agent , cohort , adverse effect , retrospective cohort study , pediatrics , bone marrow , biochemistry , gene expression , chemistry , dna methylation , gene